News | July 26, 2022
Suven Life Sciences posts Q1FY23 consolidated loss at Rs. 16.32 Cr
Suven Life Sciences has reported total income of Rs. 3.97 crores during the period ended June 30, 2022
Suven Life Sciences has reported total income of Rs. 3.97 crores during the period ended June 30, 2022
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
The company has reported total income of Rs. 186.97 crores during the period ended June 30, 2022.
The product will be manufactured at Lupin's facility in Nagpur, India.
72.5% elderly feel their generation used to spend more time with their elders, 52.4% feel lonely, shows PAN Health’s Liberty in Life of Older People 2022 survey
Bisoprolol Fumarate Tablets are used to treat high blood pressure.
Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
With this, the company can start selling Ibuprofen in the European markets.
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Subscribe To Our Newsletter & Stay Updated
